BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18956801)

  • 1. Allogeneic bone marrow transplant in Belfast--an outcome overview of the first 25 years.
    Cargo CA; Yates E; Marley C; Piggott S; McMullin MF; Jones FG
    Ulster Med J; 2008 Sep; 77(3):185-90. PubMed ID: 18956801
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry.
    Bortin MM; Horowitz MM; Gale RP
    Nat Immun Cell Growth Regul; 1988; 7(5-6):334-50. PubMed ID: 3065641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation.
    Gratwohl A; Hermans J; Barrett AJ; Ernst P; Frassoni F; Gahrton G; Granena A; Kolb HJ; Prentice HG; Vernant JP
    Bone Marrow Transplant; 1990 Mar; 5(3):159-65. PubMed ID: 2331536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-emerging Philadelphia chromosome-positive acute leukaemia more than 20 years after allogeneic haematopoietic stem cell transplantation.
    Kodama Y; Okamura J; Fukano R; Nakashima K; Ito N; Nishimura M; Abe Y; Suzuki T; Inagaki J
    Br J Haematol; 2013 Apr; 161(2):286-9. PubMed ID: 23294201
    [No Abstract]   [Full Text] [Related]  

  • 6. Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Ringdén O; Horowitz MM
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2989-92. PubMed ID: 2650409
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
    Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A
    Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias. A report from the International Bone Marrow Transplant Registry.
    Horowitz MM; Bortin MM
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):56-64. PubMed ID: 8383476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
    Enright H; Davies S; McGlave P
    Clin Transpl; 1994; ():283-93. PubMed ID: 7547549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients.
    Schattenberg A; Schaap N; Preijers F; van der Maazen R; de Witte T
    Bone Marrow Transplant; 2000 Jul; 26(1):17-22. PubMed ID: 10918401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
    Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
    Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation using unrelated marrow donors.
    Fay JW; Collins RH; Piñeiro L
    Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
    Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
    Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
    Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience.
    Aljasem HA; Messner HA; Lipton JH; Kim DDH; Viswabandya A; Thyagu S; Deotare U; Michelis FV
    Eur J Haematol; 2018 Mar; 100(3):308-314. PubMed ID: 29240253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G; Foncuberta MC; Aversa L; Drelichman G; Freigeiro D; Burgos R; Irrazabal C; Gonzalez G; Dictar M; Niborski R; Kohan A; Sanchez Avalos JC
    Medicina (B Aires); 2000; 60(2):179-87. PubMed ID: 10962806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic bone marrow transplantation from HLA-identical siblings following conditioning with busulfan and cyclophosphamide. First results.
    Wiktor-Jedrzejczak W; Szczylik C; Matej H; Pojda Z; Ratajczak MZ; Myc A; Siekierzyński M; Kansy J; Kłos M; Rybicki Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):403-8. PubMed ID: 2480281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
    Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of bone marrow cell dose in bone marrow transplantation.
    Paulin T
    Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.